October 18, 2007 - Possis Medical Inc. featured the newest and the most important advancements in its "Complete Solution for Thrombus" at TCT 2007, including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.
The AngioJet Ultra Thrombectomy System, the latest version of the AngioJet Rheolytic Thrombectomy System, is approved by the FDA for blood clot removal and reportedly reduces setup tome, improves mobility and provides a self-prompting control interface.
Sharing the same technology, Possis’ Spiroflex VG and Spiroflex catheters are the company’s most flexible and maneuverable rapid exchange catheters. The Spiroflex VG catheter provides more power than the Spiroflex catheter and is specifically designed for thrombus removal in larger peripheral and coronary vessels, while the Spiroflex catheter is uniquely suited for smaller coronary and peripheral vessel use.
The new Fetch Aspiration Catheter offers physicians another alternative for the aspiration of small, fresh blood clots and other embolic debris from arteries. According to Possis, the rapid exchange Fetch Aspiration Catheter uses an industry-standard syringe as its aspiration source. To provide the flexibility and handling that interventional procedures require, Fetch features an advanced braided shaft design used in other AngioJet thrombectomy catheters marketed by Possis.
For more information: www.possis.com